Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses.

Published

Journal Article

Recent evidence demonstrating that exposure to rapamycin during viral infection increased the quantity and quality of Ag-specific T cells poses an intriguing paradox, because rapamycin is used in transplantation to dampen, rather than enhance, donor-reactive T cell responses. In this report, we compared the effects of rapamycin on the Ag-specific T cell response to a bacterial infection versus a transplant. Using a transgenic system in which the Ag and the responding T cell population were identical in both cases, we observed that treatment with rapamycin augmented the Ag-specific T cell response to a pathogen, whereas it failed to do so when the Ag was presented in the context of a transplant. These results suggest that the environment in which an Ag is presented alters the influence of rapamycin on Ag-specific T cell expansion and highlights a fundamental difference between Ag presented by an infectious agent as compared with an allograft.

Full Text

Duke Authors

Cited Authors

  • Ferrer, IR; Wagener, ME; Robertson, JM; Turner, AP; Araki, K; Ahmed, R; Kirk, AD; Larsen, CP; Ford, ML

Published Date

  • August 2010

Published In

Volume / Issue

  • 185 / 4

Start / End Page

  • 2004 - 2008

PubMed ID

  • 20631309

Pubmed Central ID

  • 20631309

Electronic International Standard Serial Number (EISSN)

  • 1550-6606

International Standard Serial Number (ISSN)

  • 0022-1767

Digital Object Identifier (DOI)

  • 10.4049/jimmunol.1001176

Language

  • eng